Tech Company Inital Public Offerings

Durata Therapeutics IPO

Durata Therapeutics, based in Chicago, debuted as a public company on 7/19/2012.

Transaction Overview

Announced On
7/19/2012
Transaction Type
IPO
Amount
$68,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 South Wacker Dr. 2550
Chicago, IL 60606
USA
Email Address
Overview
Durata Therapeutics is a clinical, development-stage pharmaceutical company focused on the treatment of infectious diseases.
Profile
Durata Therapeutics LinkedIn Company Profile
Social Media
Durata Therapeutics Company Twitter Account
Company News
Durata Therapeutics News
Facebook
Durata Therapeutics on Facebook
YouTube
Durata Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Edick
  Paul Edick LinkedIn Profile  Paul Edick Twitter Account  Paul Edick News  Paul Edick on Facebook
Chief Medical Officer
Michael Dunne
  Michael Dunne LinkedIn Profile  Michael Dunne Twitter Account  Michael Dunne News  Michael Dunne on Facebook
Chief Operating Officer
Corey Fishman
  Corey Fishman LinkedIn Profile  Corey Fishman Twitter Account  Corey Fishman News  Corey Fishman on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/19/2012: 33Across venture capital transaction
Next: 7/19/2012: Trustnode venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary